Bausch Health Companies (BHC) Long-Term Deferred Tax (2009 - 2026)

Bausch Health Companies has disclosed Long-Term Deferred Tax across 18 years of filings, most recently posting $1.8 billion for Q1 2026.

• Long-Term Deferred Tax for Q1 2026 came in at $1.8 billion, down 6.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 billion (down 6.68% YoY), and the FY2025 annual result was $1.8 billion, down 6.35% from the prior year.
• Long-Term Deferred Tax came in at $1.8 billion for Q1 2026 at Bausch Health Companies, roughly flat from $1.8 billion in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $2.4 billion in Q3 2022 to a low of $1.8 billion in Q4 2025.
• The 5-year median for Long-Term Deferred Tax is $2.2 billion (2023), against an average of $2.1 billion.
• Across the five-year window, Long-Term Deferred Tax climbed 6.14% in 2022 and slipped 8.0% in 2025, its largest moves.
• Bausch Health Companies' Long-Term Deferred Tax stood at $2.2 billion in 2022, then retreated by 3.0% to $2.1 billion in 2023, then fell by 6.33% to $2.0 billion in 2024, then dropped by 6.35% to $1.8 billion in 2025, then gained by 0.11% to $1.8 billion in 2026.
• The last three Long-Term Deferred Tax figures came in at $1.8 billion (Q1 2026), $1.8 billion (Q4 2025), and $2.1 billion (Q3 2025), per Business Quant data.